Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Halogenated hydrocarbon doai
Patent
1995-12-01
1998-11-24
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Halogenated hydrocarbon doai
A61K 3102
Patent
active
058407677
ABSTRACT:
Perfluorotetramethylcyclohexane shows improved properties for use in biological gas exchange, both as a blood substitute and as perfluorocarbon for intra-pulmonary applications. The material has an adequately low vapor pressure to completely avoid causing hyperinflated lung damage and to increase the interval between required applications. However, the compound has a sufficiently high vapor pressure to produce acceptably brief residence time within the body. A method has been developed for using this novel compound to accelerate the exhalation of very low vapor pressure compounds such as perfluorophenanthrene from the lungs. The addition of perfluorotetramethylcyclohexane, along with perfluorophenanthrene, greatly increases the rate at which the perfluorophenanthrene is exhaled.
REFERENCES:
patent: 3911138 (1975-10-01), Clark, Jr.
patent: 4173654 (1979-11-01), Scherer
patent: 5158536 (1992-10-01), Sekins et al.
patent: 5295953 (1994-03-01), Richard et al.
patent: 5300528 (1994-04-01), Graybill et al.
patent: 5437272 (1995-08-01), Fuhrman
"Synthesis and Physical Properties of Perfluorocompounds Useful as Synthetic Blood Candidates", by R.E. More et al., Oxygen Carrying Colloidal Blood Substitutes, 1982, pp. 50-60.
Hoffman, R.E. et al., Biomat., Art. Cells & Immob. Biotech., "Arterial Blood Gases and Brain Oxygen Availability Following Infusion of Intracheal Fluorocarbon Neat Liquids," 20(2-4), pp. 1073-1083, .COPYRGT.1992 by Marcel Dekker, Inc.
Leach, C.L. et al., Critical Care Medicine, "Perfluorocarbon-associated gas exchange (partial liquid ventilation) in respitory distress syndrome: A prospective, randomized, controlled study," vol. 21, no. 9, .COPYRGT.1993 by Williams & Wilkins.
Clark, L.C., Jr. et al. Biomat., Art, Cells & Immob. Biotech., "Response of the Rabbit Lung as a Criterion of Safety for Flurocarbon Breathing and Blood Substitutes, " 20 (2-4), pp. 1085-1099, .COPYRGT.1992 by Marcel Dekker, Inc.
Tutuncu, A.S. et al., American Review of Repiratory Disease, "Comparison Ventilatory Support with Intracheal Perfluorcarbon Administration and Conventional...Acute Respiratory Failure,"vol. 148, pp. 785-792 (1993).
Samuel Schurch, John Georke, and John A. Clements, Physiological Sciences, "Direct determination of surface tension in the lung", vol. 73, No. 12, pp. 4698-4702, Dec. 1976.
Shaffer et al., Biomaterials, Artificial Cells, and Immobilization Biotechnology, "Artificial Cells, Blood Substitutes, and Immobilization Biotechology", vol. 22, No. 4, pp. 315-326 (1994).
Fay Zohreh
Synthetic Blood International, Inc.
LandOfFree
Perfluorocarbons for biological gas exchange and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Perfluorocarbons for biological gas exchange and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Perfluorocarbons for biological gas exchange and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702702